SL Science Holding Limited

US$0.94As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SLBTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (90.98%)
Mkt cap US$534.6M
ROIC (138.93%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.03
9.60%
(65.29%)
Hold 0|0|10|0|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
14.11%
7.39%
5.28%
1.34%
Revenue$M
26.43
26.44
26.23
26.67
3.20%
(2.29%)
(4.62%)
(1.12%)
Peers (US$534.6M)
Cap (US$)
PE
486.7M
—
465.7M
—
Capital
TTM
5Y
10Y
Leveragex
1.047
(0.042)
(0.028)
EBIT/Intx
0.871
0.126
0.176
Own earn%
92.23
(80.89)
(59.04)
Sh yield%
36.92
26.54
27.52
Owners
Insiders/Inst%
4.80
34.76
Short interest%
2.46
SBC / revenue%
3.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
21–29
$1 testx
0.0
Incr. ROIC%
8